SONOMA PHARMACEUTICALS, INC. Retained Earnings
SONOMA PHARMACEUTICALS, INC. (SNOA) had Retained Earnings of -$201.31 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-06
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$201.31M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$200.98M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$200.40M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$199.58M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$201.31M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | -$200.98M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | -$200.40M 10-Q · filed 2026-02-10 | |
| 2025-09-30 | -$199.58M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | -$199.05M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | -$197.81M 10-K · filed 2026-06-16 | |
| 2024-12-31 | -$197.03M 10-Q · filed 2025-02-05 | |
| 2024-09-30 | -$196.10M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | -$195.49M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | -$194.35M 10-K · filed 2025-06-17 | |
| 2023-12-31 | -$193.28M 10-Q · filed 2024-02-08 | |
| 2023-09-30 | -$192.42M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | -$190.93M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | -$189.51M 10-K · filed 2024-06-17 | |
| 2022-12-31 | -$188.21M 10-Q · filed 2023-02-14 | |
| 2022-09-30 | -$186.27M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$185.25M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | -$184.36M 10-K · filed 2023-06-21 | |
| 2021-12-31 | -$181.42M 10-Q · filed 2022-02-11 | |
| 2021-09-30 | -$180.47M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | -$180.38M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | -$179.28M 10-K · filed 2022-07-13 | |
| 2020-12-31 | -$172.54M 10-Q · filed 2021-02-16 | |
| 2020-09-30 | -$171.89M 10-Q · filed 2020-11-20 | |
| 2020-06-30 | -$172.01M 10-Q/A · filed 2020-11-17 | -$171.25M 10-Q · filed 2020-08-14 |
| 2020-03-31 | -$175.33M 10-K · filed 2021-07-14 | -$172.25M 10-K · filed 2020-07-10 |
| 2019-12-31 | -$170.87M 10-Q · filed 2020-02-14 | |
| 2019-09-30 | -$169.78M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | -$168.58M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | -$169.24M 10-K · filed 2020-07-10 | |
| 2018-12-31 | -$166.02M 10-Q · filed 2019-02-14 | |
| 2018-09-30 | -$163.72M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | -$160.90M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | -$157.44M 10-K · filed 2019-07-01 | |
| 2017-12-31 | -$152.68M 10-Q · filed 2018-02-14 | |
| 2017-09-30 | -$149.49M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | -$146.62M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | -$143.10M 10-K · filed 2018-06-26 | |
| 2016-12-31 | -$140.66M 10-Q · filed 2017-02-17 | |
| 2016-09-30 | -$156.89M 10-Q · filed 2016-11-15 | |
| 2016-06-30 | -$154.94M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | -$152.38M 10-K · filed 2017-06-28 | |
| 2015-12-31 | -$149.47M 10-Q · filed 2016-02-16 | |
| 2015-09-30 | -$146.32M 10-Q · filed 2015-11-10 | |
| 2015-06-30 | -$144.55M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | -$142.21M 10-K · filed 2016-06-21 | |
| 2014-12-31 | -$140.71M 10-Q · filed 2015-02-12 | |
| 2014-09-30 | -$134.80M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | -$134.08M 10-Q · filed 2014-08-12 | |
| 2014-03-31 | -$134.01M 10-K · filed 2015-06-16 | |
| 2013-12-31 | -$141.47M 10-Q · filed 2014-02-14 | |
| 2013-09-30 | -$140.86M 10-Q · filed 2013-11-19 | |
| 2013-06-30 | -$139.46M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | -$137.75M 10-K · filed 2014-06-30 | |
| 2012-12-31 | -$135.30M 10-Q · filed 2013-02-13 | |
| 2012-09-30 | -$133.39M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | -$131.87M 10-Q/A · filed 2012-08-31 | |
| 2012-03-31 | -$132.31M 10-K · filed 2013-06-25 | |
| 2011-12-31 | -$130.55M 10-Q · filed 2012-02-10 | |
| 2011-09-30 | -$128.00M 10-Q · filed 2011-11-03 | |
| 2011-06-30 | -$127.16M 10-Q/A · filed 2011-08-09 | |
| 2011-03-31 | -$124.98M 10-K · filed 2012-06-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |